U.S. markets closed

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
14.72+0.51 (+3.59%)
Al cierre: 04:00PM EDT
14.72 0.00 (0.00%)
Fuera de horario: 05:00PM EDT

Cytek Biosciences, Inc.

47215 Lakeview Boulevard
Fremont, CA 94538
United States
877 922 9835
https://cytekbio.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo555

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Wenbin Jiang Ph.D.Pres, CEO & Chairman568.5kN/D1964
Mr. Patrik Sebastian JeanmonodChief Financial Officer412.54kN/D1966
Dr. Ming Yan Ph.D.CTO & Director514.78kN/D1963
Dr. Allen B. Poirson Ph.D.Sr. VP of Bus. & Corp. Devel.N/DN/D1960
Mr. Melik UlusuVP of Operations & Integrated Supply ChainN/DN/DN/D
Mr. Mark EdingerVP of Scientific AffairsN/DN/DN/D
Mr. Paul D. GoodsonHead of Investor RelationsN/DN/DN/D
Ms. Valerie T. Barnett J.D.Gen. Counsel & Corp. Sec.N/DN/D1975
Ms. Connie WedelChief People OfficerN/DN/DN/D
Mr. Todd GarlandChief Commercial OfficerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2021 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Gestión corporativa

La calificación ISS Governance QuickScore de Cytek Biosciences, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.